Mindset Pharma Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.5353
- Today's High:
- $0.5375
- Open Price:
- $0.5353
- 52W Low:
- $0.1626
- 52W High:
- $0.5495
- Prev. Close:
- $0.541
- Volume:
- 1000
Company Statistics
- Market Cap.:
- $53.59 million
- Book Value:
- -0.021
- Revenue TTM:
- $7.75 million
- Operating Margin TTM:
- -69.82%
- Gross Profit TTM:
- $3.91 million
- Profit Margin:
- -78.82%
- Return on Assets TTM:
- -32.36%
- Return on Equity TTM:
- -471.07%
Company Profile
Mindset Pharma Inc had its IPO on under the ticker symbol MSSTF.
The company operates in the Healthcare sector and Biotechnology industry. Mindset Pharma Inc has a staff strength of 0 employees.
Stock update
Shares of Mindset Pharma Inc opened at $0.54 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.54 - $0.54, and closed at $0.54.
This is a -0.65% slip from the previous day's closing price.
A total volume of 1,000 shares were traded at the close of the day’s session.
In the last one week, shares of Mindset Pharma Inc have increased by +1.43%.
Mindset Pharma Inc's Key Ratios
Mindset Pharma Inc has a market cap of $53.59 million, indicating a price to book ratio of 28.8748 and a price to sales ratio of 4.8286.
In the last 12-months Mindset Pharma Inc’s revenue was $7.75 million with a gross profit of $3.91 million and an EBITDA of $0. The EBITDA ratio measures Mindset Pharma Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Mindset Pharma Inc’s operating margin was -69.82% while its return on assets stood at -32.36% with a return of equity of -471.07%.
In Q1, Mindset Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 16.6%.
Mindset Pharma Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mindset Pharma Inc’s profitability.
Mindset Pharma Inc stock is trading at a EV to sales ratio of 3.4157 and a EV to EBITDA ratio of -2.0982. Its price to sales ratio in the trailing 12-months stood at 4.8286.
Mindset Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $8.71 million
- Total Liabilities
- $10.76 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Mindset Pharma Inc ended 2024 with $8.71 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.71 million while shareholder equity stood at $-2150070.00.
Mindset Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $10.76 million in other current liabilities, in common stock, $-32616249.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.25 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Mindset Pharma Inc’s total current assets stands at $8.59 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.08 million and inventory worth $0.
In 2024, Mindset Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Mindset Pharma Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.54
- 52-Week High
- $0.5495
- 52-Week Low
- $0.1626
- Analyst Target Price
- $
Mindset Pharma Inc stock is currently trading at $0.54 per share. It touched a 52-week high of $0.5495 and a 52-week low of $0.5495. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.43 and 200-day moving average was $0.28 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 957.6% of the company’s stock are held by insiders while 7.4% are held by institutions.
Frequently Asked Questions About Mindset Pharma Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.